GAR1
Basic information
Region (hg38): 4:109815510-109824740
Previous symbols: [ "NOLA1" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the GAR1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 12 | 13 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 12 | 1 | 0 |
Variants in GAR1
This is a list of pathogenic ClinVar variants found in the GAR1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
4-109816184-G-A | not specified | Uncertain significance (Mar 25, 2024) | ||
4-109816251-C-G | not specified | Uncertain significance (Apr 08, 2024) | ||
4-109816254-AGGTGGAGGCGGC-A | GAR1-related disorder | Likely benign (Dec 07, 2022) | ||
4-109816261-G-A | not specified | Likely benign (Jan 31, 2022) | ||
4-109816354-C-G | not specified | Uncertain significance (Jun 28, 2022) | ||
4-109816364-C-T | not specified | Uncertain significance (May 03, 2023) | ||
4-109817987-C-A | not specified | Uncertain significance (Apr 12, 2025) | ||
4-109818017-A-G | not specified | Uncertain significance (Sep 12, 2023) | ||
4-109818022-C-A | not specified | Uncertain significance (Apr 07, 2025) | ||
4-109818034-G-C | not specified | Uncertain significance (Jan 19, 2025) | ||
4-109818051-T-G | not specified | Uncertain significance (Aug 21, 2023) | ||
4-109818079-C-T | not specified | Uncertain significance (Nov 25, 2024) | ||
4-109819014-A-C | not specified | Uncertain significance (Sep 29, 2023) | ||
4-109822405-G-A | not specified | Uncertain significance (Jun 24, 2022) | ||
4-109822426-G-C | not specified | Uncertain significance (Feb 12, 2024) | ||
4-109822482-A-G | not specified | Uncertain significance (Jun 07, 2024) | ||
4-109823989-G-C | not specified | Uncertain significance (Dec 11, 2024) | ||
4-109824424-G-A | not specified | Uncertain significance (Dec 15, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
GAR1 | protein_coding | protein_coding | ENST00000226796 | 6 | 9228 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.100 | 0.893 | 125717 | 0 | 5 | 125722 | 0.0000199 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.232 | 110 | 117 | 0.940 | 0.00000533 | 1349 |
Missense in Polyphen | 29 | 29.998 | 0.96673 | 409 | ||
Synonymous | 0.402 | 36 | 39.2 | 0.918 | 0.00000171 | 460 |
Loss of Function | 2.37 | 4 | 13.3 | 0.300 | 7.28e-7 | 153 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000915 | 0.0000913 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000267 | 0.0000264 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Required for ribosome biogenesis and telomere maintenance. Part of the H/ACA small nucleolar ribonucleoprotein (H/ACA snoRNP) complex, which catalyzes pseudouridylation of rRNA. This involves the isomerization of uridine such that the ribose is subsequently attached to C5, instead of the normal N1. Each rRNA can contain up to 100 pseudouridine ("psi") residues, which may serve to stabilize the conformation of rRNAs. May also be required for correct processing or intranuclear trafficking of TERC, the RNA component of the telomerase reverse transcriptase (TERT) holoenzyme. {ECO:0000269|PubMed:10757788, ECO:0000269|PubMed:15044956}.;
- Pathway
- Ribosome biogenesis in eukaryotes - Homo sapiens (human);rRNA processing;Metabolism of RNA;rRNA modification in the nucleus and cytosol;rRNA processing in the nucleus and cytosol
(Consensus)
Recessive Scores
- pRec
- 0.125
Intolerance Scores
- loftool
- 0.255
- rvis_EVS
- 0.35
- rvis_percentile_EVS
- 73.97
Haploinsufficiency Scores
- pHI
- 0.159
- hipred
- Y
- hipred_score
- 0.794
- ghis
- 0.527
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.388
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Gar1
- Phenotype
- homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- snoRNA guided rRNA pseudouridine synthesis;telomere maintenance via telomerase
- Cellular component
- nuclear chromosome, telomeric region;fibrillar center;nucleus;nucleoplasm;telomerase holoenzyme complex;box H/ACA snoRNP complex;box H/ACA scaRNP complex;box H/ACA telomerase RNP complex
- Molecular function
- RNA binding;protein binding;box H/ACA snoRNA binding;telomerase RNA binding